Search Results - "Yalamanchi, Sadasiva Rao"

Topical Esmolol Hydrochloride as a Novel Treatment Modality for Diabetic Foot Ulcers: A Phase 3 Randomized Clinical Trial by Rastogi, Ashu, Kulkarni, Sudhir A, Agarwal, Sanjay, Akhtar, Murtaza, Arsule, Sachin, Bhamre, Sudhir, Bhosle, Deepak, Desai, Sanjay, Deshmukh, Manisha, Giriraja, K V, Jagannath, Jagannath, Kashiva, Reema Yuvraj, Kesavan, Rajesh, Khandelwal, Deepak, Kolte, Sanjay, Kongara, Srikanth, Darivemula, Anil Kumar, Madhusudan, C, Pyare Saheb Qureshi, Mohammad Asif Haji, Ramu, Muthu, Rathod, Gunvant, Yalamanchi, Sadasiva Rao, Shakya, Shobhit, Shetty, Prathvi, Singh, Sudagar, Deshpande, Supreet K, Viswanathan, Vijay, Unnikrishnan, Ambika G

“…Preclinical and phase 1/2 studies with esmolol hydrochloride suggest its potential role in treatment of diabetic foot ulcers (DFUs). To study the efficacy of…”
Get full text

One-year safety and effectiveness of insulin degludec in patients with diabetes mellitus in routine clinical practice in India—TRUST (Tresiba real-world use study) by Kesavadev, Jothydev, Murthy, L.Sreenivasa, Chaudhury, Tirthankar, Yalamanchi, Sadasiva Rao, Giri, J., Gupta, Sunil, Phatak, Sanjeev, Modi, K.D., Chatterjee, Sanjay, Manjunath, Aparna, Revanna, Manjunatha, Bhattacharya, Arpandev

“…This post-authorization safety study (PASS) was conducted to evaluate the long-term safety and effectiveness of insulin degludec in patients with diabetes…”
Get full text

Safety of Insulin Degludec/Insulin Aspart in Patients with Diabetes Mellitus over a Period of 1 Year during Routine Clinical Care in India: SMART (Study of Management of Diabetes with Ryzodeg™ Treatment) by Kesavadev, Jothydev, Gowda, Ambanna, Kumar, Harish, Yalamanchi, Sadasiva Rao, Lodha, Sailesh, Singh, Kiran Pal, Basu, Debasis, Asirvatham, Arthur, Shah, Navneet, Pathan, Muzammil Khan, Revanna, Manjunatha, Mukherjee, Jagat Jyoti

“…This post-authorization study was conducted to evaluate the safety of insulin degludec/insulin aspart (IDegAsp) in adult patients with diabetes mellitus (DM)…”
Get full text

One-Year Safety and Effectiveness of Insulin Degludec in Patients with Diabetes Mellitus in Routine Clinical Practice in India—TRUST (Tresiba Real-World Use Study) by KESAVADEV, JOTHYDEV, MURTHY, L. SREENIVASA, SABOO, BANSHI D., YALAMANCHI, SADASIVA RAO, RAMANATHAN, BALAMURUGAN, GUPTA, SUNIL, CHATTERJEE, SANJAY, REVANNA, MANJUNATHA, KASETTY, HARSHA

“…Insulin degludec (degludec) is a basal insulin with an ultra-long duration of action and low day-to-day variability in the glucose-lowering effect. The aim of…”
Get full text